SUBSCRIBE
SUBSCRIBE
News   Business

Flexion Therapeutics Reports Year-End 2013 Financial Results

March 27, 2014 | 
1 min read
free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., March 27, 2014 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced financial results for the year-ended December 31, 2013.

Help employers find you! Check out all the jobs and post your resume.
Earnings
MORE ON THIS TOPIC
Fund raising Capital Donation. Funds Support Concept. Fundraising. Collecting donations in jar.
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
January 16, 2026
 · 
2 min read
 · 
Tristan Manalac
Top view of successful businessman lost in labyrinth
RNA editing
JPM26: Korro Bio Looks To Save Itself Despite Unenviable Position
January 16, 2026
 · 
3 min read
 · 
Dan Samorodnitsky
Drug pricing
Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’
January 15, 2026
 · 
2 min read
 · 
Annalee Armstrong
Contemporary art collage featuring a hand with a judicial hammer. Concept of Judge and Provost or Judgment Day
Legal
Compounder Sues Lilly, Novo, Claims Coordinated Crackdown
January 15, 2026
 · 
2 min read
 · 
Tristan Manalac